Are US payers getting to grips with cost-effectiveness analysis?

Are US payers getting to grips with cost-effectiveness analysis?

Download report

Start a conversation

An Xcenda consultant will contact you directly to discuss your needs.

Xcenda Insights

access network

Insight

Biosimilars pipeline report: A guide for understanding the growing market

AmerisourceBergen
July 2024

Lady sitting at a desk with a laptop

Insight

Unlocking AMCP Format Version 5.0: Navigating updates and best practices for formulary dossiers

AmerisourceBergen
June 2024

Insight

Unsupported policy information: Insights from Jane Ha

Jane Ha, PharmD, MS
AmerisourceBergen
June 2024